UC Davis and CDPH conduct survey of physicians on CURES

September 16, 2016
Area(s) of Interest: CURES Drug Prescribing/Dispensing 

The opioid overdose epidemic in California has brought with it heightened interest in California’s Controlled Substance Utilization Review and Evaluation System (CURES). Now, a new effort to understand CURES usage and controlled substance prescribing in California has begun under two multi-year grants to improve CURES and prevent prescription drug overdoses.

As part of the grant project, the University of California, Davis, and the California Department of Public Health – in collaboration with the Medical Board of California – are conducting a physician survey to provide insight and information regarding the prescribing of controlled substances in California. The information will also be used to help guide efforts to make CURES more user-friendly and to improve patient care and safety.

Physician participation is voluntary. The information will be analyzed only by the research team at UC Davis, and the findings will be presented only in aggregate. No personal or identifying information will be shared with payors or other parties, and individual responses will not be shared with the medical board. Individual responses will NOT be reported to the medical board or to any other state agency.

The survey has been approved by the UC Davis Institutional Review Board. If you have any questions about this survey, you can contact the project leader, Stephen Henry, M.D., at (916) 734-2177.

Physicians whose licenses expire November 30, 2016, are eligible to participate in the survey.

To take the survey, click here.


Was this article helpful?    

COVID-19 Resources

Resources for physicians and health care providers on the latest news, research and developments.

Stay Informed

Opt in to receive updates on the latest health care news, legislation, and more.

Latest News

Load More